Authors
Loading...
Review highlights improved bioavailability in osteoporosis using nanocarriers for raloxifene, indicating novel therapeutic strategies.
Kumar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: